Ara
Toplam kayıt 1, listelenen: 1-1
Comparison of ticagrelor and clopidogrel in patients with acute coronary syndrome at high bleeding or ischemic risk
(Elsevier, 2023)
Current guidelines recommend individualizing the choice and duration of P2Y12 inhibitor
therapy based on the trade-off between bleeding and ischemic risk. However, whether a
potent P2Y12 inhibitor (ticagrelor) or a less ...